Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases Eirik Ikdahl, Grunde Wibetoe,

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Fellows' perspectives on training in adult congenital heart disease: Results of a survey from the International Society for Adult Congenital Heart Disease.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Erik De Clercq International Journal of Antimicrobial Agents Volume 33,

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.

Copyright © 2015 by the American Osteopathic Association.

Robert Roberts, MD, FRCPC, MACC Canadian Journal of Cardiology

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy

Copyright © 2012 American Medical Association. All rights reserved.

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

American Journal of Kidney Diseases

The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

An Update on PCSK9 Inhibitors

Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Erik O. Udo, Norbert M. van Hemel, Nicolaas P. A

Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations Judith A. Finegold,

Alan Gradman Journal of Indian College of Cardiology

Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan

International Journal of Cardiology

Qing Ye, Wen-xia Shao, Shi-qiang Shang, Ming-ming Zhou

Unknown ankylosing spondylitis with only cardiac involvement in patient with surgical indication: Call for patient and family members immunological screening

Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? Maura Ravera, Elisabetta.

Cardiovascular disease in women with HIV-1 infection

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease Anna Maria Izquierdo-Porrera,

I. Introduction American Journal of Kidney Diseases

International Journal of Cardiology

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Guidelines for the Older Adult With CKD

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018 Marius M. Hoeper, Christian Apitz,

Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: An opportunity we cannot afford to miss Daniel Kinikini, MD, Mark R. Sarfati,

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition.

European Urology is “Your” Journal

Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus.

International Journal of Cardiology

Impact of statin dose on major cardiovascular events: A mixed treatment comparison meta-analysis involving more than 175,000 patients Rodrigo Antonini.

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Non-adherence to cardiovascular drugs in older patients with depression: A population- based cohort study Floor Holvast, Hans Wouters, Karin Hek, François.

Unattended versus attended blood pressure measurement: Mean values and determinants of the difference Anna Paini, Fabio Bertacchini, Deborah Stassaldi,

Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand Panrasri Khonputsa,

Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention Abdallah Al-Salameh, MD, Philippe Chanson,

Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5million.

Cardiovascular health, risks and diseases in contemporary China

Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations Willem J. Verberk, Stefano.

An Update on PCSK9 Inhibitors

International Journal of Cardiology

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Long-term follow-up of mitral valve regurgitation��Importance of mitral valve pathology and left ventricular function on survival Krister Lindmark,

Baseline Characteristics of the Subjects*

Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression Corline Brouwers, Stefan.

Women with Rheumatoid Arthritis: The Unspoken Risk Factor

Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into.

Volume 87, Issue 1, Pages (January 2015)

Relationships between the baseline disease activity scores and scintigraphic sum scores for the patients with RA, pSpA and axSpA. Relationships between.

Joshua R. Smith, Erik H. Van Iterson, Bruce D. Johnson, Barry A

This Month in AJKD American Journal of Kidney Diseases

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Patient-reported adherence towards different IMID treatments in RA (A), PsA (B) or AS (C). Patient-reported adherence towards different IMID treatments.

III. Treating dyslipidemias

J. David Spence, BA, MBA, MD Canadian Journal of Cardiology

Cardiovascular disease risk assessment capture rates in the NOCAR project, evaluated across diagnosis groups and participating centre. Cardiovascular disease.

International Journal of Cardiology

Presentation transcript:

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases Eirik Ikdahl, Grunde Wibetoe, Silvia Rollefstad, Anne Salberg, Kjetil Bergsmark, Tore K. Kvien, Inge C. Olsen, Dag Magnar Soldal, Gunnstein Bakland, Åse Lexberg, Bjørg Tilde Svanes Fevang, Hans Christian Gulseth, Glenn Haugeberg, Anne Grete Semb International Journal of Cardiology Volume 274, Pages 311-318 (January 2019) DOI: 10.1016/j.ijcard.2018.06.111 Copyright © 2018 Elsevier B.V. Terms and Conditions

Fig. 1 a–b. Frequencies of indications for cardiovascular disease preventive drugs, proportions of patients treated with cardiovascular disease preventive drugs and rates of treatment goal attainment, across inflammatory joint disease entities. LLT: lipid lowering treatment, AntiHT: antihypertensive treatment, RA: rheumatoid arthritis, axSpA: ankylosing spondylitis, PsA: psoriatic arthritis, LDL-c: low-density lipoprotein cholesterol, BP: blood pressure. Crude data. International Journal of Cardiology 2019 274, 311-318DOI: (10.1016/j.ijcard.2018.06.111) Copyright © 2018 Elsevier B.V. Terms and Conditions

Fig. 2 a–d. Comparisons of use of cardiovascular disease preventive drugs and treatment goal attainment, across inflammatory joint disease entities. Abbreviations as in Fig. 1. Age and sex adjusted analyses. International Journal of Cardiology 2019 274, 311-318DOI: (10.1016/j.ijcard.2018.06.111) Copyright © 2018 Elsevier B.V. Terms and Conditions

Fig. 3 a–d. Comparisons of undertreatment with cardiovascular disease preventive drugs across inflammatory joint disease entities. Abbreviations as in Fig. 1. Age and sex adjusted analyses. International Journal of Cardiology 2019 274, 311-318DOI: (10.1016/j.ijcard.2018.06.111) Copyright © 2018 Elsevier B.V. Terms and Conditions